The Michigan Supreme Court has ruled that the state attorney general may proceed with an investigation into Eli Lilly's insulin pricing practices, removing a legal barrier that had blocked the inquiry for four years. The 4-3 decision in Attorney General v. Eli Lilly and Company was issued at the end of July.
The ruling does not find that Eli Lilly did anything wrong. It resolves a procedural question about whether the state can investigate at all, and the distinction is central to reading this story accurately.
